Jul 2006 1The New Geant4 License J. Perl The New Geant4 License Makes clear the user’s wide- ranging freedom to use, extend or redistribute Geant4, even.

Slides:



Advertisements
Similar presentations
© 2008 Oracle Corporation – Proprietary and Confidential.
Advertisements

HIV/AIDS Infection and Cell Organelles. Activity 16: HIV/AIDS Infection and Cell Organelles LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be.
IMPORTANT READ CAREFULLY BEFORE USING THIS PRODUCT LICENSE AGREEMENT AND LIMITED WARRANTY BY INSTALLING OR USING THE SOFTWARE, FILES OR OTHER ELECTRONIC.
What Do Specialized Cells Do?
Content Management Systems …mostly Umbraco ALL ABOUT.
FPGA and ASIC Technology Comparison - 1 © 2009 Xilinx, Inc. All Rights Reserved How do I Get Started with PlanAhead?
Activity 11 Genomics.
Middleware Promises Warranties that Don’t Indemnities that Won’t Stephen Rubin, Esquire
Contract Review.  1. The final step in the vendor contracting process should be getting the vendor’s standard written contract and signing the contract.
DIRC Workshop on Software Quality and the Legal System 13 February 2004, Gray's Inn, London LEGAL ASPECTS OF SOFTWARE PROCUREMENT Jos Dumortier University.
Anticipated 2008 Generic Launches JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM © THOMSON REUTERS.
Adding Genes This presentation gives a quick overview on how to add Genes to Osprey.
X3D Graphics for Web Authors X3D-Edit Update SIGGRAPH 2008 Don Brutzman Naval Postgraduate School Monterey California USA.
17-1 JXTA Developer and Business Resources Module Objectives ● Understand JXTA's Open Source Model ● Learn how to get involved at jxta.org ● Learn.
Blue Diamond Scott Auge Amduus Information Works, Inc.
MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.
End User License Agreement Permission to use and redistribute this Document is granted, provided that (1) the below copyright notice appears in all copies.
Andrew McNab - License issues - 10 Apr 2002 License issues for EU DataGrid (on behalf of Anders Wannanen) Andrew McNab, University of Manchester
NRCCL (University of Oslo, Faculty of Law) Copyleft and Open Source Jon Bing Notrwegian Research Center for Computers and Law Master Lecture 13 October.
Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©
Mitosis and Asexual Reproduction
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2014 by Standard.
Paragraph IV Patent Challenges – As of July 1, 2008 JULY 2008 David Harding, API Intelligence, Thomson Reuters Source: FDA, NEWPORT HORIZON PREMIUM TM.
Copyright ©2006 CA. All rights reserved. All trademarks, trade names, services marks and logos referenced herein belong to their respective companies.
Proportion of biotech-derived active substances in development for first launch 31st December APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Our Global Community. Activity 1: Our Global Community LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
DNA Replication. Activity 12: DNA Replication LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently teaching.
International Telecommunication Union New Delhi, India, December 2011 ITU Workshop on Standards and Intellectual Property Rights (IPR) Issues Philip.
Changing Databases This presentation gives a quick overview on how to change databases in Osprey.
Comprehensive Volume, 18 th Edition Chapter 27: Warranties and Other Product Liability Theories.
Life in Other Countries. Activity 2: Life in Other Countries LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
National Alliance for Medical Image Computing Licensing in NAMIC 3 requirements from NCBC RFA (paraphrased)
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Receipts.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Outbound Logistics (L3) Pick Loads.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Put Away Loads.
A Model Membrane. Activity 7: A Model Membrane LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently teaching.
LIMITED LICENSE TO MODIFY
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage Supplier Returns.
Proportion of total R&D expenditure by therapeutic area in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS Your.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Manage and Disposition Inventory Returns.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
Oracle Fusion Applications 11gR1 ( ) Functional Overview (L2) Manage Inbound Logistics (L3) Inspect Material.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
The Tragedy of the Commons. Activity 5: The Tragedy of the Commons LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers.
Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.
Sustainability Case Studies. Activity 3: Sustainability Case Studies LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers.
Nomenclature for the OGSA Platform document Fred Maciel.
Regulatory approval times between submission and marketing authorization approval APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM.
Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.
Allocation of R&D expenditure in 2005 between chemical entity and biological or biotech active substances APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Copyright ©2006 CA. All rights reserved. All trademarks, trade names, services marks and logos referenced herein belong to their respective companies.
Ideas about Evolution. Activity 14: Ideas about Evolution LIMITED LICENSE TO MODIFY. These PowerPoint® slides may be modified only by teachers currently.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
Copyright © 2012, Oracle and/or its affiliates. All rights reserved. Oracle Proprietary and Confidential. 1.
Four Ways Suppliers Limit Their Risk Contractually
Connectivity to bank and sample account structure
OGSA Service Classifications
City of Toronto Open Data
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Comparative Law of Licenses and Contracts in the US, UK and EU
4) Flow control Logical operators, comparative operators Instructions:
Automation in an XML Authoring Environment
Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA
Self-Registration walk-through
Representations and Warranties Indemnification Liability Caps
Motivation for 36OU Open Rack
GNU General Public License (GPL)
© Healthcare Inspirations. All rights reserved
2019 MEDICARE AGE-IN STUDY SENIOR MARKET INSIGHTS SERVICE Part IV
Presentation transcript:

Jul The New Geant4 License J. Perl The New Geant4 License Makes clear the user’s wide- ranging freedom to use, extend or redistribute Geant4, even as part of some for-profit venture. Makes clear the user’s wide- ranging freedom to use, extend or redistribute Geant4, even as part of some for-profit venture. The license was released along with the latest Geant4 release 8.1. The license was released along with the latest Geant4 release 8.1. Simple enough that you can read and understand it. Simple enough that you can read and understand it. In response to user requests for clarification of Geant4’s distribution policy, the collaboration recently announced a new license

Jul The New Geant4 License J. Perl The New Geant4 License Installation, use, reproduction, display, modification and redistribution of this software, with or without modification, in source and binary forms, are permitted on a non- exclusive basis. Any exercise of rights by you under this license is subject to the following conditions: 1. Redistributions of this software, in whole or in part, with or without modification, must reproduce the above copyright notice and these license conditions in this software, the user documentation and any other materials provided with the redistributed software. 2. The user documentation, if any, included with a redistribution, must include the following notice: "This product includes software developed by Members of the Geant4 Collaboration ( )." If that is where third-party acknowledgments normally appear, this acknowledgment must be reproduced in the modified version of this software itself. 3. The names "Geant4” and “The Geant4 toolkit” may not be used to endorse or promote software, or products derived therefrom, except with prior written permission by If this software is redistributed in modified form, the name and reference of the modified version must be clearly distinguishable from that of this software. License has 8 points. The points are written clearly and simply. 1,2 and 3) Tell the world who the software came from, and don’t claim you are us.

Jul The New Geant4 License J. Perl The New Geant4 License 4. You are under no obligation to provide anyone with any modifications of this software that you may develop, including but not limited to bug fixes, patches, upgrades or other enhancements or derivatives of the features, functionality or performance of this software. However, if you publish or distribute your modifications without contemporaneously requiring users to enter into a separate written license agreement, then you are deemed to have granted all Members and all Copyright Holders of the Geant4 Collaboration a license to your modifications, including modifications protected by any patent owned by you, under the conditions of this license. 5. You may not include this software in whole or in part in any patent or patent application in respect of any modification of this software developed by you. 4) If you choose to give it away free to everyone, we can have it for free too. 5) You can’t patent the parts we did.

Jul The New Geant4 License J. Perl The New Geant4 License 6. DISCLAIMER THIS SOFTWARE IS PROVIDED BY THE MEMBERS AND COPYRIGHT HOLDERS OF THE GEANT4 COLLABORATION AND CONTRIBUTORS "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY, OF SATISFACTORY QUALITY, AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE DISCLAIMED. THE MEMBERS OF THE GEANT4 COLLABORATION AND CONTRIBUTORS MAKE NO REPRESENTATION THAT THE SOFTWARE AND MODIFICATIONS THEREOF, WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADE SECRET OR OTHER PROPRIETARY RIGHT. 7. LIMITATION OF LIABILITY THE MEMBERS AND COPYRIGHT HOLDERS OF THE GEANT4 COLLABORATION AND CONTRIBUTORS SHALL HAVE NO LIABILITY FOR DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES OF ANY CHARACTER INCLUDING, WITHOUT LIMITATION, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES, LOSS OF USE, DATA OR PROFITS, OR BUSINESS INTERRUPTION, HOWEVER CAUSED AND ON ANY THEORY OF CONTRACT, WARRANTY, TORT (INCLUDING NEGLIGENCE), PRODUCT LIABILITY OR OTHERWISE, ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 8. This license shall terminate with immediate effect and without notice if you fail to comply with any of the terms of this license, or if you institute litigation against any Member or Copyright Holder of the Geant4 Collaboration with regard to this software. We don’t claim that it works, and we’re not responsible if it doesn’t.

Jul The New Geant4 License J. Perl The New Geant4 License Through the generous support of many governments and institutions, you, the community, have already paid for Geant4. Through the generous support of many governments and institutions, you, the community, have already paid for Geant4. We, the Geant4 collaboration, want you to enjoy the software and use it where ever you can. We, the Geant4 collaboration, want you to enjoy the software and use it where ever you can. That’s it